Use of thiopental sodium intravenously in the presence of hepatic damage; an experimental study.
D000007:Abdominal Injuries; D001462:Barbital / Q000031:analogs & derivatives; D006296:Health Services; D008099:Liver; D008107:Liver Diseases; D013874:Thiopental
D001462:Barbital; D013874:Thiopental
BARBITAL DERIVATIVES; LIVER